Cibc World Market Inc. Increases Position in HCA Healthcare, Inc. $HCA

Cibc World Market Inc. lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 59.4% during the 4th quarter, HoldingsChannel reports. The firm owned 57,654 shares of the company’s stock after purchasing an additional 21,480 shares during the quarter. Cibc World Market Inc.’s holdings in HCA Healthcare were worth $26,916,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Capital World Investors increased its stake in shares of HCA Healthcare by 3.8% in the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock worth $2,113,662,000 after acquiring an additional 179,443 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after purchasing an additional 13,565 shares during the period. Norges Bank acquired a new position in HCA Healthcare in the 4th quarter valued at about $1,262,513,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of HCA Healthcare by 1.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after buying an additional 36,414 shares during the last quarter. Finally, Viking Global Investors LP lifted its holdings in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after acquiring an additional 690,773 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.3%

Shares of HCA Healthcare stock opened at $362.27 on Friday. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The company has a 50 day moving average of $441.74 and a 200 day moving average of $477.94. The company has a market capitalization of $80.37 billion, a P/E ratio of 12.46, a P/E/G ratio of 1.15 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on HCA shares. UBS Group upped their price target on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research note on Monday, February 23rd. Weiss Ratings lowered shares of HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, May 18th. Sanford C. Bernstein decreased their price objective on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a report on Thursday. JPMorgan Chase & Co. cut their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 19th. Finally, Mizuho lifted their price objective on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $506.14.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.